A Study to Find the Best Dose of BI 905711 in Combination With Chemotherapy and to Test Whether This Dose Helps People With Advanced Gastrointestinal Cancers
Clinical trial NCT05087992 · COMPLETED
Trial details
- NCT number
- NCT05087992
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-24
- Primary completion
- 2023-10-23
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.